Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker SKWD
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 5, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Aug 20, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Aug 20, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Aug 4, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jul 15, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 11, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 6, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 26, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 23, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jan 6, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jan 6, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jan 6, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Jan 6, 2026 | SKWD Skyward Specialty Insurance Group, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 3, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 18, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Nov 18, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 18, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 12, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 12, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 29, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Sep 8, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Sep 8, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jul 30, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 13, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 13, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 1, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 25, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 5, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 5, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Feb 5, 2025 | SKWD Skyward Specialty Insurance Group, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 29, 2024 | SKWD Skyward Specialty Insurance Group, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 29, 2024 | SKWD Skyward Specialty Insurance Group, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Oct 29, 2024 | SKWD Skyward Specialty Insurance Group, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
33 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:51 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances